Nicotine addiction: Mechanisms and consequences

International Journal of Mental Health

Volumn 40, Issue 1, 2011, Pages 22-38

  Rosenthal, David G ^a   Weitzman, Michael ^a   Benowitz, Neal L ^b,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79957864202     PISSN: 00207411     EISSN: None     Source Type: Journal    
DOI: 10.2753/IMH0020-7411400102     Document Type: Article

References (109)

1. Jiang, J.; Liu, B.; Sitas, F.; Li, J.; Zeng, X.; Han, W.; et al. (2010) Smokingattributable deaths and potential years of life lost from a large, representative study in China. Tobacco Control, 19(1), 7-12.
2. Mathers, C., & Loncar, D. (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3(11), e442-e442.
3. Doll, R.; Peto, R.; Boreham, J.; & Sutherland, I. (2004) Mortality in relation to smoking: 50 years' observations on male British doctors. British Medical Journal, 328(7455), 1519-1519.
4. Das, S. (2003) Harmful health effects of cigarette smoking. Molecular and Cellular Biochemistry, 253(1-2), 159-165. (Pubitemid 37321722)
5. Benowitz, N. (2010) Nicotine addiction. New England Journal of Medicine, 362(24), 2295-2303.
6. Bartal, M. (2001) Health effects of tobacco use and exposure. Monaldi Archives for Chest Disease, 56(6), 545-554. (Pubitemid 34406655)
7. Cigarette smoking among adults and trends in smoking cessation-United States, 2008. (2009) Morbidity and Mortality Weekly Report, 58(44), 1227-1232.
8. CDC grand rounds: Current opportunities in tobacco control. (2010) Morbidity and Mortality Weekly Report, 59(16), 487-492.
9. Taly, A.; Corringer, P.-J.; Guedin, D.; Lestage, P.; & Changeux, P.J. (2009) Nicotinic receptors: Allosteric transitions and therapeutic targets in the nervous system. Nature Reviews Drug Discovery, 8(9), 733-750.
10. Dajas-Bailador, F., & Wonnacott, S. (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends in Pharmacological Sciences, 25(6), 317-324. (Pubitemid 38692424)
11. Changeux, J.-P. (2010) Nicotine addiction and nicotinic receptors: Lessons from genetically modified mice. Nature Reviews. Neuroscience, 11(6), 389-401.
12. Changeux, J.P., & Edelstein, S.J. (2005) Nicotinic acetylcholine receptors: From molecular biology to cognition. New York: Odile Jacob.
13. Tapper, A.; McKinney, S.L.; Nashmi, R.; Schwarz, J.; Deshpande, P.; Labaraca, C.; et al. (2004) Nicotine activation of alpha4* receptors: Sufficient for reward, tolerance, and sensitization. Science, 306(5698), 1029-1032. (Pubitemid 39482905)
14. Maskos, U.; Molles, B.E.; Pons, S.; Besson, M.; Guiard, B.P.; Guilloux, J.P.; et al. (2005) Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature, 436(7047), 103-107. (Pubitemid 40966193)
15. Mineur, Y., & Picciotto, M. (2008) Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction. Biochemical Pharmacology, 75(1), 323-333. (Pubitemid 350235388)
16. Tapia, L.; Kuryatov, A.; & Lindstrom, J. (2007) Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors. Molecular Pharmacology, 71(3), 769-776.
17. Aberger, K.; Chitravanshi, V.C.; & Sapru, H.N. (2001) Cardiovascular responses to microinjections of nicotine into the caudal ventrolateral medulla of the rat. Brain Research, 892(1), 138-146. (Pubitemid 32126577)
18. Nestler, E. (2005) Is there a common molecular pathway for addiction? Nature Neuroscience, 8(11), 1445-1449. (Pubitemid 41573654)
19. Davis, J., & Gould, T. (2009) Hippocampal nAChRs mediate nicotine withdrawal- related learning deficits. European Neuropsychopharmacology, 19(8), 551-561.
20. Koob, G. (2008) A role for brain stress systems in addiction. Neuron, 59(1), 11-34. (Pubitemid 351905857)
21. Naqvi, N., & Bechara, A. (2009) The hidden island of addiction: The insula. Trends in Neurosciences, 32(1), 56-67.
22. Salas, R.; Sturm, R.; Boulter, J.; & De Biasi, M. (2009) Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. Journal of Neuroscience, 29(10), 3014-3018.
23. Laviolette, S., & van der Kooy, D. (2004) The neurobiology of nicotine addiction: Bridging the gap from molecules to behaviour. Nature Reviews Neuroscience, 5(1), 55-65. (Pubitemid 38076184)
24. Mansvelder, H.D., & McGehee, D.S. (2000) Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron, 27(2), 349-357.
25. Johnson, P.; Hollander, J.; & Kenny, P. (2008) Decreased brain reward function during nicotine withdrawal in C57BL6 mice: Evidence from intracranial selfstimulation (ICSS) studies. Pharmacology, Biochemistry and Behavior, 90(3), 409-415.
26. Kenny, P., & Markou, A. (2006) Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology, 31(6), 1203-1211. (Pubitemid 43971837)
27. O'Dell, L., & Khroyan, T. (2009) Rodent models of nicotine reward: What do they tell us about tobacco abuse in humans? Pharmacology, Biochemistry and Behavior, 91(4), 481-488.
28. Brody, A. (2006) Functional brain imaging of tobacco use and dependence. Journal of Psychiatric Research, 40(5), 404-418. (Pubitemid 43816583)
29. Sharma, A., & Brody, A.L. (2009) In vivo brain imaging of human exposure to nicotine and tobacco. Handbook of Experimental Pharmacology, 12(192), 145-171.
30. Hollander, J.; Lu, Q.; Cameron, M.D.; Kamenecka, T.M.; & Kenny, P.J. (2008) Insular hypocretin transmission regulates nicotine reward. Proceedings of the National Academy of Sciences of the United States of America, 105(49), 19480-19485.
31. van Amsterdam, J.; Talhout, R.; Vleeming, W.; & Opperhuizen, A. (2006) Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction. Life Sciences, 79(21), 1969-1973. (Pubitemid 44528577)
32. Lewis, A.; Miller, J.H.; & Lea, R.A. (2007) Monoamine oxidase and tobacco dependence. Neurotoxicology, 28(1), 182-195. (Pubitemid 46187252)
33. Fowler, J.; Logan, J.; Wang, G.J.; & Volkow, N.D. (2003) Monoamine oxidase and cigarette smoking. Neurotoxicology, 24(1), 75-82. (Pubitemid 36091163)
34. Giniatullin, R.; Nistri, A.; & Yakel, J. (2005) Desensitization of nicotinic ACh receptors: Shaping cholinergic signaling. Trends in Neurosciences, 28(7), 371-378. (Pubitemid 40853860)
35. Picciotto, M.; Addy, N.A.; Mineur, Y.S.; & Brunzell, D.H. (2008) It is not "either/or": Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Progress in Neurobiology, 84(4), 329-342.
36. Wang, H., & Sun, X. (2005) Desensitized nicotinic receptors in brain. Brain Research Reviews, 48(3), 420-437. (Pubitemid 40725400)
37. Govind, A.; Vezina, P.; & Green, W. (2009) Nicotine-induced upregulation of nicotinic receptors: Underlying mechanisms and relevance to nicotine addiction. Biochemical Pharmacology, 78(7), 756-765.
38. Dani, J., & Harris, R.A. (2005) Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nature Neuroscience, 8(11), 1465-1470. (Pubitemid 41573657)
39. Brody, A.; Mandelkern, M.A.; Costello, M.R.; Abrams, A.L.; Scheibal, D.; Farahi, J.; et al. (2009) Brain nicotinic acetylcholine receptor occupancy: Effect of smoking a denicotinized cigarette. International Journal of Neuropsychopharmacology, 12(3), 305-316.
40. Cosgrove, K.; Batis, J.; Bois, F.; Maciejewski, P.K.; Esterlis, I.; Kloczynski, T.; et al. (2009) Beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Archives of General Psychiatry, 66(6), 666-676.
41. Balfour, D.J.K. (2004) The neurobiology of tobacco dependence: A preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected]. Nicotine and Tobacco Research, 6(6), 899-912. (Pubitemid 40124750)
42. Koob, G. (2009) Dynamics of neuronal circuits in addiction. Pharmacopsychiatry, 42(Suppl. 1), S32-S41.
43. Le Moal, M., & Koob, G. (2007) Drug addiction: Pathways to the disease and pathophysiological perspectives. European Neuropsychopharmacology, 17(6-7), 377-393. (Pubitemid 46497657)
44. George, O.; Ghozland, S.; Azar, M.R.; Cottone, P.; Zorrilla, E.P.; Parsons, L.H.; et al. (2007) CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proceedings of the National Academy of Sciences of the United States of America, 104(43), 17198-17203. (Pubitemid 350211014)
45. Marcinkiewcz, C.; Prado, M.M.; Isaac, S.K.; Marshall, A.; Rylkova, D.; & Bruijnzeel, A.W. (2009) Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology, 34(7), 1743-1752.
46. Evans, D., & Drobes, D. (2009) Nicotine self-medication of cognitive-attentional processing. Addiction Biology, 14(1), 32-42.
47. Knott, V, Heenan, A.; Shah, D.; Bolton, K.; Fisher, D.; & Villeneuve, C. (2009) Electrophysiological evidence of nicotine's distracter-filtering properties in non-smokers. Journal of Psychopharmacology, 25(2), 239-248.
48. Hughes, J. (2007) Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine and Tobacco Research, 9(3), 315-327. (Pubitemid 46404264)
49. Hughes, J.R., & Hatsukami, D. (1986) Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43(3), 289-294. (Pubitemid 16052281)
50. Koob, G.F., & Le Moal, M. (1997) Drug abuse: Hedonic homeostatic dysregulation. Science, 278(5335), 52-58. (Pubitemid 27446270)
51. Hughes, J. (2006) Clinical significance of tobacco withdrawal. Nicotine and Tobacco Research, 8(2), 153-156. (Pubitemid 43675071)
52. Davis, J., & Gould, T. (2008) Associative learning, the hippocampus, and nicotine addiction. Current Drug Abuse Reviews, 1(1), 9-19.
53. Kauer, J., & Malenka, R. (2007) Synaptic plasticity and addiction. Nature Reviews Neuroscience, 8(11), 844-858. (Pubitemid 350006216)
54. Kenney, J., & Gould, T. (2008) Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Molecular Neurobiology, 38(1), 101-121.
55. Olausson, P.; Jentsch, J.D.; & Taylor, J. (2004) Repeated nicotine exposure enhances responding with conditioned reinforcement. Psychopharmacology, 173(1-2), 98-104. (Pubitemid 38591152)
56. Kenny, P., & Markou, A. (2005) Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. Journal of Neuroscience, 25(26), 6208-6212. (Pubitemid 40923487)
57. Rose, J. (2006) Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology, 184(3-4), 274-285. (Pubitemid 43255844)
58. Rose, J.E.; Behm, F.M.; & Levin, E.D. (1993) Role of nicotine dose and sensory cues in the regulation of smoke intake. Pharmacology, Biochemistry and Behavior, 44(4), 891-900.
59. Rose J.E.; Behm F.M.; Westman E.C.; & Johnson M. (2000) Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacology, Biochemistry and Behavior, 67(1), 71-81.
60. Naqvi, N.; Rudrauf, D.; Damasio, H.; & Bechara, H. (2007) Damage to the insula disrupts addiction to cigarette smoking. Science, 315(5811), 531-534. (Pubitemid 46175760)
61. Vorel, S.; Bisaga, A.; McKhann, G.; & Kleber, H.D. (2007) Insula damage and quitting smoking. Science, 317(5836), 318-319.
62. Samaha, A.-N.; Yaua, W.-Y.W.; Yanga, P.; & Robinsona, T.E. (2005) Rapid delivery of nicotine promotes behavioral sensitization and alters its neurobiological impact. Biological Psychiatry, 57(4), 351-360. (Pubitemid 40215764)
63. Henningfield, J.E.; Benowitz, N.L.; Connolly, G.N.; Davis, R.M.; Gray, N.; Myers, M.L.; et al. (2004) Reducing tobacco addiction through tobacco product regulation. Tobacco Control, 13(2), 132-135. (Pubitemid 39452013)
64. Houtsmuller, E.; Henningfield, J.; & Stitzer, M. (2003) Subjective effects of the nicotine lozenge: Assessment of abuse liability. Psychopharmacology, 167(1), 20-27. (Pubitemid 36535288)
65. Shiffman, S. (2008) Effect of nicotine lozenges on affective smoking withdrawal symptoms: Secondary analysis of a randomized, double-blind, placebocontrolled clinical trial. Clinical Therapeutics, 30(8), 1461-1475.
66. Guthrie, S.K.; Minoshima, S.; Ohl, L.; Zubieta, J.-K.; Koeppe, R.A.; Domino, E.F.; & Guthrie, S.K. (1999) Arterial/venous plasma nicotine concentrations following nicotine nasal spray. European Journal of Clinical Pharmacology, 55(9), 639-643.
67. Henningfield, J.E.; Stapleton, J.M.; Benowitz, N.L.; Grayson, R.F.; & London, E.D. (1993) Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug and Alcohol Dependence, 33(1), 23-29. (Pubitemid 23219906)
68. Benowitz, N.L. (2001) Compensatory smoking of low yield cigarettes. In D.R. Shopland, D.M. Burns, N.L. Benowitz, & R.H. Amacher (Eds.), Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine (pp. 39-64). (NCI Monograph 13). Bethesda, MD: National Cancer Institute.
69. Benowitz, N.L. (1992) Cigarette smoking and nicotine addiction. Medical Clinics of North America, 76(2), 415-437.
70. Shiffman, S. (2009) Light and intermittent smokers: Background and perspective. Nicotine and Tobacco Research, 11(2), 122-125.
71. Levy, D.; Biener, L.; & Rigotti, N. (2009) The natural history of light smokers: A population-based cohort study. Nicotine and Tobacco Research, 11(2), 156-163.
72. Al Koudsi, N., & Tyndale, R. (2005) Genetic influences on smoking: A brief review. Therapeutic Drug Monitoring, 27(6), 704-709. (Pubitemid 44391719)
73. Lessov-Schlaggar, C.; Pergadia, M.L.; Khroyan, T.V.; & Swan, G.E. (2008) Genetics of nicotine dependence and pharmacotherapy. Biochemical Pharmacology, 75(1), 178-195. (Pubitemid 350235400)
74. Xian, H.; Scherrer, J.F.; Madden, P.A.; Lyons, M.J.; Tsuang, M.; True, WR.; et al. (2005) Latent class typology of nicotine withdrawal: Genetic contributions and association with failed smoking cessation and psychiatric disorders. Psychological Medicine, 35(3), 409-419. (Pubitemid 40372479)
75. Benowitz, N.L. (2008) Clinical pharmacology of nicotine: Implications for understanding, preventing, and treating tobacco addiction. Clinical Pharmacology and Therapeutics, 83(4), 531-541. (Pubitemid 351417076)
76. Ho, M.K., & Tyndale, R.F. (2007) Overview of the pharmacogenomics of cigarette smoking. Pharmacogenomics Journal, 7(2), 81-98. (Pubitemid 46577845)
77. Bierut, L.; Madden, P.A.F.; Breslau, N.; Johnson, E.O.; Hatsukami, D.; Pomerleau, O.F.; et al. (2007) Novel genes identified in a high-density genome wide association study for nicotine dependence. Human Molecular Genetics, 16(1), 24-35. (Pubitemid 46152542)
78. Saccone, N.; Saccone, S.F.; Hinrichs, A.L.; Stitzel, J.A.; Duan, W.; Pergadia, M.L.; et al. (2009) Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics, 150B(4), 453-466.
79. Saccone, S.; Hinrichs, A.L.; Saccone, N.L.; Chase, G.A.; Konvicka, K.; Madden, P.A.F.; et al. (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human Molecular Genetics, 16(1), 36-49. (Pubitemid 46152543)
80. Uhl, G.R.; Liu, Q.-R.; Drgon, T.; Johnson, C.; Walther, D.; & Rose, J.E. (2007) Molecular genetics of nicotine dependence and abstinence: Whole genome association using 520,000 SNPs. BMC Genetics, 8, 10.
81. Keskitalo, K.; Broms, U.; Heliövaara, M.; Ripatti, S.; Surakka, I.; Perola, M.; et al. (2009) Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15. Human Molecular Genetics, 18(20), 4007-4012.
82. Le Marchand, L.; Derby, K.S.; Murphy, S.E.; Hecht, S.S.; Hatsukami, D.; Carmella, S.G.; et al. (2008) Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Research, 68(22), 9137-9140.
83. Pillai, S.; Ge, D.; Zhu, G.; Kong, X.; Shianna, K.V.; Need, A.C.; et al. (2009) A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genetics, 5(3), e1000421-e1000421.
84. Hung, R.; McKay, J.D.; Gaborieau, V.; Boffetta, P.; Hashibe, M.; Zaridze, D.; et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452(7187), 633-637. (Pubitemid 351483367)
85. Amos, C.; Wu, X.; Broderick, P.; Gorlov, I.P.; Gu, P.; Eisen, T.; et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nature Genetics, 40(5), 616-622. (Pubitemid 351601203)
86. Spitz, M.; Amos, C.I.; Dong, Q.; Lin, J.; & Wu, X. (2008) The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. Journal of the National Cancer Institute, 100(21), 1552-1556.
87. Thorgeirsson, T.; Geller, F.; Sulem, P.; Rafnar, T.; Wiste, A.; Magnusson, K.P.; et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 452(7187), 638-642. (Pubitemid 351483366)
88. Berrettini, W.; Yuan, X.; Tozzi, F.; Song, K.; Francks, C.; Chilcoat, H.; et al. (2008) Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Molecular Psychiatry, 13(4), 368-373. (Pubitemid 351399826)
89. Thunnissen, F. (2009) Acetylcholine receptor pathway and lung cancer. Journal of Thoracic Oncology, 4(8), 943-946.
90. Cigarette use among high school students-United States, 1991-2009. (2010) Morbidity and Mortality Weekly Report, 59(26), 797-801.
91. Kandel, D.; Schaffran, C.; Griesler, P.; Samuolis, J.; Davies, M.; & Galanti, R. (2005) On the measurement of nicotine dependence in adolescence: Comparisons of the mFTQ and a DSM-IV-based scale. Journal of Pediatric Psychology, 30(4), 319-332. (Pubitemid 40629159)
92. Johnston, L.D.; O'Malley, P.M.; Bachman, J.G.; & Schulenberg, J.E. (2007) Monitoring the future national results on adolescent drug use: Overview of key findings, 2006. (NIH Publication No. 07-6202). Bethesda, MD: National Institute on Drug Abuse.
93. O'Callaghan, F.; O'Callaghan, M.; Najman, J.M.; Williams, G.M.; Bor, W.; & Alati, R. (2006) Prediction of adolescent smoking from family and social risk factors at 5 years, and maternal smoking in pregnancy and at 5 and 14 years. Addiction, 101(2), 282-290. (Pubitemid 43351602)
94. Dwyer, J.; McQuown, S.; & Leslie, F. (2009) The dynamic effects of nicotine on the developing brain. Pharmacology and Therapeutics, 122(2), 125-139.
95. Placzek, A.; Zhang, T.; & Dani, J. (2009) Age dependent nicotinic influences over dopamine neuron synaptic plasticity. Biochemical Pharmacology, 78(7), 686-692.
96. Kalman, D.; Morissette, S.; & George, T. (2005) Co-morbidity of smoking in patients with psychiatric and substance use disorders. American Journal on Addictions, 14(2), 106-123. (Pubitemid 40577885)
97. Degenhardt, L., & Hall, W. (2001) The relationship between tobacco use, substance-use disorders and mental health: Results from the National Survey of Mental Health and Well-being. Nicotine and Tobacco Research, 3(3), 225-234. (Pubitemid 32821650)
98. Lasser, K.; Boyd, W.; Woolhandler, S.; Himmelstein, D.U.; McCormick, D.; & Bor, D.H. (2000) Smoking and mental illness: A population-based prevalence study. JAMA, 284(20), 2606-2610.
99. Martin, L.F., & Freedman, R. (2007) Schizophrenia and the alpha7 nicotinic acetylcholine receptor. International Review of Neurobiology, 78, 225-246.
100. Ziedonis, D.; Hitsman, B.; Beckham, J.C.; Zvolensky, M.; Adler, L.E.; Audrain-McGovern, J.; et al. (2008) Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research, 10(12), 1691-1715.
101. Perkins, K.; Doyle, T.; Ciccocioppo, M.; Conklin, C.; Sayette, M.; & Caggiula, A. (2006) Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology, 184(3-4), 600-607. (Pubitemid 43255876)
102. Perkins, K.; Jacobs, L.; Sanders, M.; & Caggiula, A.R. (2002) Sex differences in the subjective and reinforcing effects of cigarette nicotine dose. Psychopharmacology, 163(2), 194-201. (Pubitemid 35013611)
103. Perkins, K., & Scott, J. (2008) Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine and Tobacco Research, 10(7), 1245-1250.
104. Benowitz, N.; Lessov-Schlaggar, C.N.; Swan, G.E.; & Jacob, P. (2006) Female sex and oral contraceptive use accelerate nicotine metabolism. Clinical Pharmacology and Therapeutics, 79(5), 480-488.
105. Hukkanen, J.; Jacob, P.; & Benowitz, N. (2005) Metabolism and disposition kinetics of nicotine. Pharmacological Reviews, 57(1), 79-115. (Pubitemid 40283970)
106. Malaiyandi, V.; Sellers, E.; & Tyndale, R. (2005) Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clinical Pharmacology and Therapeutics, 77(3), 145-158. (Pubitemid 40269130)
107. Rubinstein, M.; Benowitz, N.L.; Auerback, G.M.; & Moscicki, A.-B. (2008) Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers. Pediatrics, 122(3), e643-e647.
108. Lerman, C.; Tyndale, R.; Patterson, F.; Wileyto, E.P.; Shields, G.S.; Pinto, A.; et al. (2006) Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clinical Pharmacology and Therapeutics, 79(6), 600-608. (Pubitemid 43817942)
109. Rollema, H.; Chambers, L.K.; Coe, J.W.; Glowa, J.; Hurst, R.S.; Lebel, L.A.; et al. (2007) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology, 52(3), 985-994. (Pubitemid 46227486)